Laboratory of Enzymology, Department of Biochemistry, Faculty of Biology, Sofia University, Sofia, Bulgaria.
Adv Protein Chem Struct Biol. 2012;87:117-53. doi: 10.1016/B978-0-12-398312-1.00005-6.
The neurotoxin Vipoxin has been of growing research interest since the time of its isolation from the venom of the Bulgarian viper Vipera ammodytes meridionalis. Vipoxin is a heterodimeric postsynaptic ionic complex composed of two protein subunits-a basic and strongly toxic His48 secretory phospholipase A(2) (sPLA(2)) enzyme and an acidic, enzymatically inactive and nontoxic component, originally named Inhibitor. When separated, sPLA(2) enzyme loses its toxicity in 3-4 days and catalytic activity in 2 weeks. After the establishment of the high degree of sequence homology (62%) and crystal structure of the subunits, Vipoxin was served as an example of molecular evolution of a toxic but unstable sPLA(2) into an inhibitor subunit which stabilizes the enzyme and preserves its pharmacological activity. Beginning our research on Vipoxin, intrigued by the unique relationship-structure-function and based on the previous experience, we were more than surprised to establish the lack of so-called inhibitory function of the acidic subunit on the toxicity and catalytic activity of basic sPLA(2). On the contrary, the acidic subunit activated the sPLA(2) enzyme in vitro. Our studies undoubtedly proved that is more correctly to present Vipoxin as a heterodimeric complex composed of one basic catalytic subunit and one acidic regulatory subunit. Their interaction in a common quaternary protein structure is more than a noncovalent association between the two subunits. It allows pharmacological sites to be targeted and biological functions to be potentiated. We attempt to present the previous studies and new findings on Vipoxin and its components.
自从从保加利亚蝰蛇 Vipera ammodytes meridionalis 的毒液中分离出神经毒素 Vipoxin 以来,它一直是研究的热点。Vipoxin 是一种异源二聚体突触后离子复合物,由两个蛋白质亚基组成-一种碱性和强毒性 His48 分泌型磷脂酶 A2(sPLA2)酶和一种酸性、无酶活性和无毒的成分,最初命名为抑制剂。分离后,sPLA2 酶在 3-4 天内失去毒性,在 2 周内失去催化活性。在确定了亚基的高度序列同源性(62%)和晶体结构后,Vipoxin 被用作有毒但不稳定的 sPLA2 转化为稳定酶并保留其药理学活性的抑制剂亚基的分子进化的范例。在我们开始研究 Vipoxin 时,被这种独特的关系-结构-功能所吸引,并且基于以前的经验,我们惊讶地发现酸性亚基对碱性 sPLA2 的毒性和催化活性缺乏所谓的抑制作用。相反,酸性亚基在体外激活了 sPLA2 酶。我们的研究无疑证明,更正确的是将 Vipoxin 呈现为由一个碱性催化亚基和一个酸性调节亚基组成的异源二聚体复合物。它们在共同的四级蛋白质结构中的相互作用不仅仅是两个亚基之间的非共价结合。它允许靶向药理学位点并增强生物学功能。我们试图呈现关于 Vipoxin 及其成分的以前的研究和新发现。